December 2016 - Buhlmann Diagnostics Corp

Month: December 2016

Higher sensitivity detecting anti-myelin-associatedglycoprotein (MAG) IgM autoantibody using antigen purified from human brain

BÜHLMANN Anti-MAG Autoantibodies ELISA: Jaskowski et al. Higher sensitivity detecting anti-myelin-associatedglycoprotein (MAG) IgM autoantibody using antigen purified from human brain. 8th International Congress of Neuroimmunology. October 15-19, 2006.  Nagoya, Japan. Highlights from this Publication "The MAG EIA showed excellent sensitivity (97.5%) when compared to Western blot and has the advantages of being objective...and identifying [subjects] that
Continue Reading

Basophil Activation Testing – Standardized

3 Reasons to Consider this Method in Kinase Inhibitor Drug Development Basophils are the circulating immune cells that participate in allergic reactions and share many of the signaling pathways that are also present in other types of immune cells that may develop into blood cancers or participate in the development of autoimmune disorders.  Therefore, measuring
Continue Reading

Safe Use of Stool Extracts on Clinical Chemistry Analyzers

BÜHLMANN fCAL® turbo is for Research Use Only. Not to be used in diagnostic procedures. Health Canada License: 96808 BÜHLMANN fCAL® turbo Stool extracts used in the BÜHLMANN fCAL® turbo on clinical chemistry analyzers can be applied without any concern of system contamination. BÜHLMANN investigated this new sample matrix with the goal to exclude potential risks.
Continue Reading